Home LiteratureArticle Details
PMID: 16452569 Published · ppublish English Letter Comment

Assessing EGFR mutations.

The New England journal of medicine ·Vol. 354 ·No. 5 ·2006-02-02 ·Pages 526-8; author reply 526-8

Marchetti A, Felicioni L, Buttitta F

Abstract

暂无摘要

MeSH Terms
Carcinoma, Non-Small-Cell Lung/drug therapy,genetics,mortality Colonic Neoplasms/genetics DNA Mutational Analysis/methods ErbB Receptors/genetics Erlotinib Hydrochloride Humans Lung Neoplasms/drug therapy,genetics,mortality Mutation Paraffin Embedding Polymerase Chain Reaction Protein Kinase Inhibitors/therapeutic use Quinazolines/therapeutic use Sequence Deletion Survival Analysis
Chemicals
Protein Kinase Inhibitors Quinazolines Erlotinib Hydrochloride ErbB Receptors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Marchetti Antonio
Felicioni Lara
Buttitta Fiamma
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2006-02-02
Pages
526-8; author reply 526-8
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]